Patient Engagement Solutions Market by Component (Hardware, Software & Services), Delivery mode (On-Premise, Web & Cloud), End User (Provider & Payer), Applications (Home Health, Financial Health), Therapeutic Area - Global Forecast to 2020

患者エンゲージメントソリューションの世界市場:ハードウェア、ソフトウェア、サービス

◆タイトル:Patient Engagement Solutions Market by Component (Hardware, Software & Services), Delivery mode (On-Premise, Web & Cloud), End User (Provider & Payer), Applications (Home Health, Financial Health), Therapeutic Area - Global Forecast to 2020
◆商品コード:MAM-HIT-2767
◆調査・発行会社:MarketsandMarkets
◆発行日:2016年3月16日
◆ページ数:232
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:IT
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、患者エンゲージメントソリューションの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、構成要素別分析、導入方式別分析、需要先別分析、用途別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The patient engagement solutions market is projected to reach USD 16.39 Billion by 2020 from USD 6.68 Billion in 2015, growing at a CAGR of 19.7%. North America is expected to account for the largest share of the market in 2015, followed by Europe, Asia, and the Rest of the World (RoW). However, the European region is expected to grow at the highest CAGR during the forecast period.

In this report, the global patient engagement solutions market is segmented on the basis of component, delivery mode, end user, application, and therapeutic area. On the basis of component, the market is segmented into hardware, software, and services. The software segment is estimated to account for the largest share of the global market in 2015. However, the services segment is expected to witness the highest growth rate during the forecast period, owing to the indispensable nature of services which include consulting, storage, and implementation of solutions, training, maintenance, and regular upgrades.

Patient engagement solutions find major applications in the health management of a patient. These solutions are also used in social and behavioral management, home health management, and financial management. The health management segment is the fastest-growing segment and is expected to command the largest share of the global market in 2015. Providers are encouraging patients to adopt health management solutions as they help save time for providers as well as increase patient compliance with therapy. Health management solutions empower patients to improve the quality of care, resulting in better outcomes with fast recovery.

Factors such as legislations and initiatives to promote ‘patient-centeredness’ in healthcare, increasing number of accountable care organizations, impetus on fulfilling the requirements of Meaningful Use through patient engagement, growth of the HCIT market, consolidation of healthcare providers, and growing focus on eHealth are driving the growth of the market. However, reluctance among providers towards the adoption of patient engagement solutions, requirement of infrastructural investments, and lack of interoperability are expected to restrain market growth. On the other hand, emerging economies in the Asian region, growing medical tourism, and growing use of cloud-based models offer growth opportunities for players in the market.

Geographically, the patient engagement solutions market is categorized into North America, Europe, Asia, and the Rest of the World (RoW).

McKesson Corporation (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), Phytel, Inc. (U.S.), athenahealth, Inc. (U.S.), Orion Health Ltd. (New Zealand), Cerner Corporation (U.S.), GetWellNetwork, Inc. (U.S.), Lincor Solutions Ltd. (U.S.), YourCareUniverse, Inc. (U.S.), WelVU, Inc. (U.S.), Get Real Health (U.S.), Oneview Healthcare (U.S.), PatientPoint (U.S.), and Medecision, Inc. (U.S.) are the key players in the global patient engagement solutions market.

【レポートの目次】

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 24)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.3 Key Data From Secondary Sources
2.3.1 Primary Research
2.3.2 Key Industry Insights
2.4 Key Data From Primary Sources
2.5 Key Insights From Primary Sources
2.6 Market Size Estimation Methodology
2.7 Market Forecast Methodology
2.8 Market Data Validation and Triangulation
2.9 Assumptions

3 Executive Summary (Page No. – 34)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 40)
4.1 Global Patient Engagement Solutions Market
4.2 Geographic Analysis: Market, By End User
4.3 Market, By Component (2015 vs 2020)

5 Market Overview (Page No. – 44)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Government Regulations and Initiatives
5.3.1.2 Growing Popularity of Patient Engagement Solutions Among the Aging Population
5.3.1.3 Significant Investments By Stakeholders
5.3.1.4 Rising Number of Collaborations and Partnerships Between Vendors and End Users
5.3.1.5 Increasing Utilization of Mobile Health (Mhealth)
5.3.2 Restraints
5.3.2.1 Reluctance Among Providers Towards the Adoption of Patient Engagement Solutions
5.3.2.2 Requirement of Infrastructural Investments
5.3.2.3 Protection of Patient Information
5.3.2.4 Lack of Interoperability
5.3.3 Opportunities
5.3.3.1 Emerging Economies in the Asian Region
5.3.3.2 Growing Medical Tourism
5.3.3.3 Wearable Health Technology
5.3.3.4 Cloud-Based Models
5.3.4 Challenges
5.3.4.1 High Cost of Deployment
5.3.4.2 Lack of Health Literacy
5.3.4.3 Dearth of Skilled It Professionals in the Healthcare Industry

6 Adoption Assessment of Patient Engagement Solutions Market in the U.S. (Page No. – 58)
6.1 Introduction
6.1.1 U.S.: Patient Engagement Solutions Adoption Assessment, By Vendor
6.1.1.1 Medical Information Technology, Inc.
6.1.1.2 Eclinicalworks
6.1.1.3 Athenahealth, Inc.
6.1.1.4 Allscripts Healthcare Solutions, Inc.
6.1.2 U.S.: Patient Engagement Solutions Adoption Assessment, By Solution

7 Patient Engagement Solutions Market, By Component (Page No. – 63)
7.1 Introduction
7.2 Software
7.2.1 Standalone Software
7.2.2 Integrated Software
7.3 Services
7.4 Hardware

8 Patient Engagement Solutions Market, By Delivery Mode (Page No. – 70)
8.1 Introduction
8.2 Web-Based
8.3 On-Premise
8.4 Cloud-Based

9 Patient Engagement Solutions Market, By End User (Page No. – 75)
9.1 Introduction
9.2 Providers
9.3 Payers
9.4 Individual Users
9.5 Others

10 Patient Engagement Solutions Market, By Application (Page No. – 82)
10.1 Introduction
10.2 Health Management
10.3 Social and Behavioral Management
10.4 Home Health Management
10.5 Financial Health Management

11 Patient Engagement Solutions Market, By Therapeutic Area (Page No. – 88)
11.1 Introduction
11.2 Chronic Diseases
11.2.1 Diabetes
11.2.2 Cardiovascular Disease
11.2.3 Obesity
11.2.4 Other Chronic Diseases
11.3 Women’s Health
11.4 Fitness
11.5 Other Therapeutic Areas

12 Patient Engagement Solutions Market, By Region (Page No. – 98)
12.1 Introduction
12.2 North America
12.2.1 U.S.
12.2.1.1 Legislations and Initiatives to Promote ‘Patient-Centeredness’ in Healthcare
12.2.1.2 Increasing Number of Accountable Care Organizations
12.2.1.3 Need to Curb Healthcare Costs
12.2.1.4 Focus on Shared Decision-Making
12.2.1.5 Hospital Readmissions Reduction Program (HRRP)
12.2.1.6 Pharmaceuticals Industry Propelling the Patient Engagement Solutions Market in U.S.
12.2.1.7 Increase in Insurance Coverage
12.2.1.8 Increasing Investments in Patient Engagement
12.2.1.9 Impetus on Fulfilling the Requirements of ‘Meaningful Use’ Through Patient Engagement
12.2.1.10 Thrust Given to Api in Stage 3 Meaningful Use Rules
12.2.2 Canada
12.2.2.1 Digital Health Measures
12.2.2.2 Prevalence of Chronic Diseases
12.2.2.3 Patient Engagement, A Prerequisite for Accreditation
12.3 Europe
12.3.1 Rising Healthcare Costs and Aging Population
12.3.2 Growth of the Hcit Market and Consolidation of Healthcare Providers in Europe
12.3.3 Growing Focus on Ehealth
12.3.4 Germany
12.3.4.1 Rising Demand for Advanced Healthcare Solutions and Efficient Healthcare Delivery in Germany
12.3.5 U.K.
12.3.5.1 Role of the Nhs
12.3.6 France
12.3.6.1 Implementation of the Dossier Médical Personnel (DMP) in France
12.3.7 Rest of Europe (RoE)
12.4 Asia
12.4.1 Growth in Medical Tourism
12.4.2 Need to Control Rising Healthcare Expenditure in India
12.4.3 Japan’s Ict Policies
12.4.4 ‘One Singaporean, One Health Record’ Program
12.4.5 Growth of China’s Digital Healthcare
12.4.6 “Digital India” Campaign and Digital Healthcare Scenario in India
12.5 Rest of the World
12.5.1 Prevalence of Chronic Diseases
12.5.2 Increased Healthcare Spending in the Middle East
12.5.3 Growth of the Hcit Market in Latin America
12.5.4 Product Deployments and Hcit Programs in Australia

13 Competitive Landscape (Page No. – 147)
13.1 Overview
13.2 Competitive Situation and Trends
13.2.1 Product Deployments
13.2.2 Agreements, Partnerships, and Collaborations
13.2.3 New Product Launches and Product Enhancements
13.2.4 Expansions
13.2.5 Acquisitions
13.2.6 Other Strategies

14 Company Profiles (Page No. – 155)
14.1 Introduction
14.2 Mckesson Corporation
14.2.1 Business Overview
14.2.2 Products Offered
14.2.3 Recent Developments
14.2.4 MnM View
14.3 Allscripts Healthcare Solutions, Inc.
14.3.1 Business Overview
14.3.2 Products & Services Offered
14.3.3 Recent Developments
14.3.4 MnM View
14.4 Phytel, Inc. (Acquired By IBM Corporation)
14.4.1 Business Overview
14.4.2 Products Offered
14.4.3 Recent Developments
14.4.4 MnM View
14.5 Athenahealth, Inc.
14.5.1 Business Overview
14.5.2 Products & Services Offered
14.5.3 Recent Developments
14.5.4 MnM View
14.6 Cerner Corporation
14.6.1 Business Overview
14.6.2 Products Offered
14.6.3 Recent Developments
14.6.4 MnM View
14.7 Orion Health Ltd.
14.7.1 Business Overview
14.7.2 Products Offered
14.7.3 Recent Developments
14.8 Getwellnetwork, Inc.
14.8.1 Business Overview
14.8.2 Products Offered
14.8.3 Recent Developments
14.9 Lincor Solutions Ltd.
14.9.1 Business Overview
14.9.2 Products Offered
14.9.3 Recent Developments
14.10 Yourcareuniverse, Inc.
14.10.1 Business Overview
14.10.2 Products Offered
14.10.3 Recent Developments
14.11 Welvu, Inc.
14.11.1 Business Overview
14.11.2 Products Offered
14.11.3 Recent Developments
14.12 Get Real Health
14.12.1 Business Overview
14.12.2 Products and Services Offered
14.12.3 Recent Developments
14.13 Oneview Healthcare
14.13.1 Business Overview
14.13.2 Products Offered
14.13.3 Recent Developments
14.14 Patientpoint
14.14.1 Business Overview
14.14.2 Recent Developments
14.15 Medecision Inc.
14.15.1 Business Overview
14.15.2 Products Offered
14.15.3 Recent Developments
14.16 EMMI Solutions, LLC
14.16.1 Business Overview
14.16.2 Products & Services Offered
14.16.3 Recent Developments

15 Appendix (Page No. – 206)
15.1 Discussion Guide
15.2 Other Developments, By Company (2013-2016)
15.2.1 Mckesson Corporation
15.2.2 Allscripts Healthcare Solutions, Inc.
15.2.3 Phytel (Acquired By IBM)
15.2.4 Athenahealth, Inc.
15.2.5 Orion Health Ltd.
15.2.6 Cerner Corporation
15.2.7 Getwellnetwork, Inc.
15.2.8 Lincor Solutions Ltd.
15.2.9 Yourcareuniverse, Inc.
15.2.10 Get Real Health
15.2.11 Oneview Healthcare
15.2.12 Patientpoint
15.2.13 Medecision Inc.
15.2.14 EMMI Solutions, LLC
15.3 Introducing RT: Real-Time Market Intelligence
15.4 Available Customizations
15.5 Related Reports

List of Tables (95 Tables)

Table 1 Federal Mandates are Propelling the Growth of Global Patient Engagement Solutions Market
Table 2 Indicative List of Collaborations Between Organizations From 2013-2015
Table 3 Reluctance Among Providers for the Adoption of Patient Engagement Solutions Acts as A Key Restraint
Table 4 Cloud-Based Patient Engagement Solutions Offer A Huge Potential for the Market Growth
Table 5 Lack of Health Literacy is A Major Challenge for the Market
Table 6 Top Three Patient Engagement Solutions Deployed (Jan 2013-Jan 2016)
Table 7 Global Patient Engagement Solutions Market Size, By Component, 2013–2020 (USD Million)
Table 8 Patient Engagement Software Market Size, By Region, 2013–2020 (USD Million)
Table 9 Patient Engagement Software Market Size, By Type, 2013–2020 (USD Million)
Table 10 Patient Engagement Standalone Software Market Size, By Region, 2013–2020 (USD Million)
Table 11 Patient Engagement Integrated Software Market Size, By Region, 2013–2020 (USD Million)
Table 12 Patient Engagement Services Market Size, By Region, 2013–2020 (USD Million)
Table 13 Patient Engagement Hardware Market Size, By Region, 2013–2020 (USD Million)
Table 14 Global Patient Engagement Solutions Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 15 Web-Based Patient Engagement Solutions Market Size, By Region, 2013–2020 (USD Million)
Table 16 On-Premise Market Size, By Region, 2013–2020 (USD Million)
Table 17 Cloud-Based Market Size, By Region, 2013–2020 (USD Million)
Table 18 Global Patient Engagement Solutions Market Size, By End User, 2013–2020 (USD Million)
Table 19 Patient Engagement Solutions Market Size for Healthcare Providers, By Region, 2013–2020 (USD Million)
Table 20 Patient Engagement Solutions Market Size for Healthcare Payers, By Region, 2013–2020 (USD Million)
Table 21 Patient Engagement Solutions Market Size for Individual Users, By Region, 2013–2020 (USD Million)
Table 22 Patient Engagement Solutions Market Size for Others, By Region, 2013–2020 (USD Million)
Table 23 Global Market Size, By Application, 2013–2020 (USD Million)
Table 24 Patient Engagement Solutions Market Size for Health Management, By Region, 2013–2020 (USD Million)
Table 25 Market Size for Social and Behavioral Management, By Region, 2013–2020 (USD Million)
Table 26 Market Size for Home Health Management, By Region, 2013–2020 (USD Million)
Table 27 Market Size for Financial Health Management, By Region, 2013–2020 (USD Million)
Table 28 Global Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 29 Market Size for Chronic Diseases, By Region, 2013–2020 (USD Million)
Table 30 Market Size for Chronic Diseases, By Type, 2013–2020 (USD Million)
Table 31 Market Size for Diabetes, By Region, 2013–2020 (USD Million)
Table 32 Market Size for Cardiovascular Disease, By Region, 2013–2020 (USD Million)
Table 33 Market Size for Obesity, By Region, 2013–2020 (USD Million)
Table 34 Market Size for Other Chronic Diseases, By Region, 2013–2020 (USD Million)
Table 35 Market Size for Women’s Health, By Region, 2013–2020 (USD Million)
Table 36 Market Size for Fitness, By Region, 2013–2020 (USD Million)
Table 37 Market Size for Other Therapeutic Areas, By Region, 2013–2020 (USD Million)
Table 38 Market Size, By Region, 2013–2020 (USD Million)
Table 39 North America: Market Size, By Country, 2013–2020 (USD Million)
Table 40 North America: Market Size, By Component, 2013–2020 (USD Million)
Table 41 North America: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 42 North America: Market Size, By End User, 2013–2020 (USD Million)
Table 43 North America: Market Size, By Application, 2013–2020 (USD Million)
Table 44 North America: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 45 U.S.: Market Size, By Component, 2013–2020 (USD Million)
Table 46 U.S.: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 47 U.S.: Market Size, By End User, 2013–2020 (USD Million)
Table 48 U.S.: Market Size, By Application, 2013–2020 (USD Million)
Table 49 U.S.: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 50 Canada: Market Size, By Component, 2013–2020 (USD Million)
Table 51 Canada: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 52 Canada: Market Size, By End User, 2013–2020 (USD Million)
Table 53 Canada: Market Size, By Application, 2013–2020 (USD Million)
Table 54 Canada: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 55 Indicative List of Ehealth Projects Undertaken By the European Union
Table 56 Europe: Market Size, By Region, 2013–2020 (USD Million)
Table 57 Europe: Market Size, By Component, 2013–2020 (USD Million)
Table 58 Europe: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 59 Europe: Market Size, By End User, 2013–2020 (USD Million)
Table 60 Europe: Market Size, By Application, 2013–2020 (USD Million)
Table 61 Europe: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 62 Germany: Market Size, By Component, 2013–2020 (USD Million)
Table 63 Germany: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 64 Germany: Market Size, By End User, 2013–2020 (USD Million)
Table 65 Germany: Market Size, By Application, 2013–2020 (USD Million)
Table 66 Germany: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 67 U.K.: Market Size, By Component, 2013–2020 (USD Million)
Table 68 U.K.: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 69 U.K.: Market Size, By End User, 2013–2020 (USD Million)
Table 70 U.K.: Market Size, By Application, 2013–2020 (USD Million)
Table 71 U.K.: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 72 France: Market Size, By Component, 2013–2020 (USD Million)
Table 73 France: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 74 France: Market Size, By End User, 2013–2020 (USD Million)
Table 75 France: Market Size, By Application, 2013–2020 (USD Million)
Table 76 France: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 77 RoE: Market Size, By Component, 2013–2020 (USD Million)
Table 78 RoE: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 79 RoE: Market Size, By End User, 2013–2020 (USD Million)
Table 80 RoE: Market Size, By Application, 2013–2020 (USD Million)
Table 81 RoE: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 82 Asia: Market Size, By Component, 2013–2020 (USD Million)
Table 83 Asia: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 84 Asia: Market Size, By End User, 2013–2020 (USD Million)
Table 85 Asia: Market Size, By Application, 2013–2020 (USD Million)
Table 86 Asia: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 87 RoW: Market Size, By Component, 2013–2020 (USD Million)
Table 88 RoW: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 89 RoW: Market Size, By End User, 2013–2020 (USD Million)
Table 90 RoW: Market Size, By Application 2013–2020 (USD Million)
Table 91 RoW: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 92 Product Deployments, 2013–2016
Table 93 Agreements, Partnerships, and Collaborations 2013–2016
Table 94 New Product Launches and Product Enhancements, 2013–2016
Table 95 Other Developments, 2013–2016

List of Figures (34 Figures)

Figure 1 Global Patient Engagement Market: Research Methodology Steps
Figure 2 Sampling Frame: Primary Research
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Research Design
Figure 7 Data Triangulation Methodology
Figure 8 North America Dominates the Global Market in 2015
Figure 9 Providers Segment to Grow at the Highest CAGR From 2015 to 2020
Figure 10 Europe to Witness the Highest Growth Rate During the Forecast Period
Figure 11 Patient Engagement Solutions to Register Double Digit Growth in the Forecast Period
Figure 12 North America Dominates the Market in 2015
Figure 13 European Region to Witness the Highest Growth Rate During the Forecast Period
Figure 14 Software Segment Commands the Largest Share of the Market in 2015
Figure 15 Global Patient Engagement Solutiona Market
Figure 16 Drivers, Restraints, Opportunities, & Challenges
Figure 17 Leading Vendors Providing Patient Engagement Solutions to Healthcare Providers (Jan 2013–Jan 2016)
Figure 18 Patient Engagement Solutions Adopted in U.S. (Jan 2013 to Jan 2016)
Figure 19 Patient Engagement Software Market, By Type
Figure 20 Healthcare Providers to Account for the Largest Share of Market in 2015
Figure 21 Europe to Grow at the Highest CAGR in the Patient Engagement Solutions Market in 2015
Figure 22 U.S. Commands the Largest Share in the Patient Engagement Solutions Market in North America
Figure 23 Germany Commands the Largest Share of the Patient Engagement Solutions Market in Europe
Figure 24 Asia Commands for the Third Largest Market Share of the Global Patient Engagement Solutions Market
Figure 25 Providers in End-Users Segment Dominates RoW Patient Engagement Solutions Market
Figure 26 Top 5 Strategies Adopted By Players During 2013-2016
Figure 27 Battle for Market Share: Agreements, Collaborations, and Partnerships Was the Key Strategy Adopted By Market Players (2013–2016)
Figure 28 Geographic Revenue Mix of Market Players
Figure 29 Mckesson Corporation: Company Snapshot
Figure 30 Allscripts Healthcare Solutions, Inc.: Company Snapshot
Figure 31 IBM Corporation: Company Snapshot
Figure 32 Athenahealth, Inc.: Company Snapshot
Figure 33 Cerner Corporation: Company Snapshot
Figure 34 Orion Health Ltd.: Company Snapshot

【レポートのキーワード】

患者エンゲージメント、ハードウェア、ソフトウェア、サービス、クラウド、ウェブ、医療、ヘルスケア、ITシステム

★調査レポート[患者エンゲージメントソリューションの世界市場:ハードウェア、ソフトウェア、サービス] ( Patient Engagement Solutions Market by Component (Hardware, Software & Services), Delivery mode (On-Premise, Web & Cloud), End User (Provider & Payer), Applications (Home Health, Financial Health), Therapeutic Area - Global Forecast to 2020 / MAM-HIT-2767) 販売に関する免責事項
[患者エンゲージメントソリューションの世界市場:ハードウェア、ソフトウェア、サービス] ( Patient Engagement Solutions Market by Component (Hardware, Software & Services), Delivery mode (On-Premise, Web & Cloud), End User (Provider & Payer), Applications (Home Health, Financial Health), Therapeutic Area - Global Forecast to 2020 / MAM-HIT-2767) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆